Debridement using Piezosurgical Device and Incorporation of Autologous Platelet-Rich Fibrin in Management of Stage III Medication-Related Osteonecrosis of the Jaw — A Case study and Review of Literature-Reference-Cited by-同舟云学术

Debridement using Piezosurgical Device and Incorporation of Autologous Platelet-Rich Fibrin in Management of Stage III Medication-Related Osteonecrosis of the Jaw — A Case study and Review of Literature

Published:2024-01-23 Issue: Volume: Page:
ISSN:0972-2068
Container-title:Indian Journal of Surgery
language:en
Short-container-title:Indian J Surg

Author:

Chatterjee Aishwarya,Sahni Manish,Singh Suresh,Jain Sandeep,Jasuja Sandeep,Sharma Rajgovind,Bhandari Sudhir

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12262-024-04040-x.pdf

Reference20 articles.

1. Ruggiero SI, Dodson TB, Fantasia J et al (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72:1938–1956

2. NH Beth-Tasdogan, B Mayer, H Hussein, O Zolk. 2017 Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev, Issue 10. Art. No.: CD012432. DOI: https://doi.org/10.1002/14651858.CD012432.pub2

3. Khosla S et al (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the american society for bone and mineral research. J Bone Miner Res 22:1479–1491. https://doi.org/10.1359/JBMR.0707ONJ

4. Del Fabbro Massimo, Gallesio Giorgia, Mozzati Marco (2015) Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature. Eur J Cancer 51:62–74

5. Hong Mu, Pang Y, Liu L, Liu J, Liu C (2023) Clinical values of serum Semaphorin 4D (Sema4D) in medication-related osteonecrosis of the jaw. Eur J Med Res 28:140